|Dr Xiao Shu, Head Medical Investment Portfolio, Ascendin Fund and B-Core Consulting are new Parters in China
Dr Xiao Shu, a young but very seasoned cross-boarder investment fund manager in Beijing at Ascendin Fund as a new individual Partner. B-Core Consulting Inc., a Beijing based consulting firm supporting clients with market assessment on the ground in China with KOL and patient interviews, due diligence, price and reimbursement issues etc., is a new corporate partner.
All Business Development in Life Sciences or as the company is named, ABD Life Sciences Ltd., is a boutique consulting firm based in Hong Kong SAR. We conduct business development activities for clients in the life science area across Asia with a focus on "greater" China, South Korea, and Japan, also supporting access to ASEAN and South Asia, as well as for Asian companies seeking business opportunities in Europe and North America.
ABD Life Sciences Ltd. business model operates with a network of partners and professional experts in virtual teams to deliver best business solution to our customers. In 2018, ABD celebrating its 14th anniversary since establishing in Hong Kong, September 2004. During these years, we have expanded our network and deepened the coverage of pharma, biopharma, diagnostics, Med Tech, and other life science areas in ASEAN, "greater" China, South Korea, and Japan. Our services have benefited customers mainly from EU and US, enhancing their business integration in the region, but we also taken on clients from Asia and helping them dealing with cross border dealing in EU and US or with other Asian countries.
On the ABD Life Sciences website, you will find information About us, our well proven and trusted senior Partners working together as a virtual company, the tailored Services we offer for the biotech, biopharma, pharma, diagnostic, and Med Tech companies taking on Business Development, Marketing & Sales, Procurement & Outsourcing, Pre-clinical & Clinical Development and GMP & Regulatory issues.
On the Partners link, you will see our outstanding network of People and Companies that allows ABD to tap into extra resources and expertise in business development, drug development, GMP / regulatory, market, and sales knowledge. These are experienced people to handle cross-cultural challenges, working seamlessly in the virtual company business model. Our goal is to help you – the Client – understand and prepare your organisation to enter or to expand in these complex and diverse markets. We conduct market assessments, gap-analysis, provide business intelligence, regional business and marketing planning, strategies, risk analysis and mitigation strategies, door-opening, deal making and due diligence services, having the understanding of both Western and local Regulatory frameworks. In our network we have the right people with wide variety of specialties in Research and Development, pre-clinical and clinical trial, commercial operation, and regulatory expertise mixed with the necessary business experiences gain from MNC and small medium enterprises. We can help to open the doors to local partners and assist in concluding a deal. Whether the deal is distribution, R&D collaboration and out-licensing, our services are intended to meet the client’s business goals and expectations.
Under References, you can read about some of the different tasks we have taken on and accomplished so far.
Let ABD Life Sciences help you capitalise on Asia’s exciting opportunities in life sciences. Contact us today!